Embryotoxicity of the intercalating agents m‐AMSA and o‐AMSA and the epipodophyllotoxin VP‐16 in postimplantation rat embryos in vitro
- 6 June 1990
- journal article
- research article
- Published by Wiley in Teratology
- Vol. 41 (6), 679-688
- https://doi.org/10.1002/tera.1420410604
Abstract
The intercalating agent, m‐AMSA, and the epipodophyllotoxin, VP‐16, both topoisomerase II—reactive anticancer agents, are also embryotoxic agents in rat embryos cultured in vitro. Quantifying the embryotoxic effects of these drugs revealed that the no observed adverse effect level (NOAEL) for m‐AMSA is 10 nM, the embryotoxic concentration range is 50–500 nM, and complete lethality is observed at 1 μM. In contrast, the NOAEL for o‐AMSA, an inactive isomer of m‐AMSA, is 1.0 μM, the embryotoxic concentration range is 10–100 μM, and complete lethality occurs at 200 μM. Based upon the concentrations of drugs required to produce 50% embryotoxicity or 50% malformed embryos, m‐AMSA exhibits a 200–500‐fold‐higher embryotoxicity compared to o‐AMSA. VP‐16 exhibits a NOAEL of 1.0 μM, an embryotoxic concentration range of 2–5 μM, and complete lethality at 10 μM. Compared to m‐AMSA, VP‐16 is approximately 10‐fold less embryotoxic. At appropriate concentrations, all three drugs were dysmorphogenic resulting in embryos that were characterized by hypoplasia of the prosencephalon with associated microopthalmia and dilation of the rhombencephalon. As a prelude to future studies focusing on the mechanism of drug‐induced embryotoxicity, we have used established biochemical and immunologic methods to identify and quantify topoisomerase II in rat embryos. In addition, we have demonstrated that the embryo topoisomerase II can be inhibited by both m‐AMSA and VP‐16. Finally, we have used a human cDNA probe to detect topoisomerase II mRNA in the rat embryo. Thus, the combination of the in vitro whole embryo culture and these biochemical/molecular assays should allow us to explore the role of a specific nuclear target, i.e., topoisomerase II, in the teratogenic effects of some commonly employed chemotherapeutic agents.This publication has 40 references indexed in Scilit:
- Cell cycle analysis in the cardiac and neuroepithelial tissues of day 10 rat embryos and the effects of phosphoramide mustard, the major teratogenic metabolite of cyclophosphamideTeratology, 1989
- DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombeCell, 1987
- Hyperthermia-induced heat shock response and thermotolerance in postimplantation rat embryosDevelopmental Biology, 1987
- Teratology study in rats with amsacrine, an antineoplastic agent*1Fundamental and Applied Toxicology, 1986
- Novobiocin blocks the Drosophila heat shock responseJournal of Molecular Biology, 1985
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitroToxicology and Applied Pharmacology, 1984
- Teratogenicity of cyclophosphamide metabolites: Phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitroToxicology and Applied Pharmacology, 1981
- Teratogenic and cytogenetic effects of some plant‐derived antitumor agents (vincristine, colchicine, maytansine, VP‐16‐213 and VM‐26) in miceTeratology, 1978
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976